Allergan signs up to Editas’ genome editing tech
admin 15th March 2017 Uncategorised 0Allergan has secured itself exclusive access to Editas Medicine’s genome-editing ocular programmes under a strategic research and development pact between the two firms.
More: Allergan signs up to Editas’ genome editing tech
Source: News